NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I’m not sure sitting on the shelf is a fair context. Dr. Bosch worked his arse off since the phase I Direct trial in order to:

1. Correlate hundreds of phase I observations from, blood, tumor tissue, biochemistry, DC phenotype and genotype, tumor and patient status before during and after therapy was ultimately (unfortunately) stopped, etc. fact.
2. Fine tune the process, from what he learned in phase I, that develops and picks out the ultimate partially matured DCs, and where not possible because of some DC deficiency, devising the process to get DCs to become partially matured warriors. Fact.
3. Developed and patented these methods so that his therapy does not go into the waste bin of unprofitable breakthroughs. Fact.
4. Await the end to the intolerably slow (likely) approval of L, so that his therapy can be well funded in phase ii/iii trials for all solid tumor indications, imo.